Dr Paul Erick Hogsten, MD | |
500 W Fort St, Crh # 444, Fl 2, Boise, ID 83702-4501 | |
(208) 422-1018 | |
(208) 422-1038 |
Full Name | Dr Paul Erick Hogsten |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 500 W Fort St, Boise, Idaho |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265619563 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | D35401 (Maryland) | Primary |
2084P0802X | Psychiatry & Neurology - Addiction Psychiatry | D35401 (Maryland) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Paul Erick Hogsten, MD 500 W Fort St, Crh # 444, Fl 2, Boise, ID 83702-4501 Ph: (208) 422-1018 | Dr Paul Erick Hogsten, MD 500 W Fort St, Crh # 444, Fl 2, Boise, ID 83702-4501 Ph: (208) 422-1018 |
News Archive
Two T cell biomarkers appear to predict the survival trajectory of patients with idiopathic pulmonary fibrosis (IPF), a lung disease that has a varied, but ultimately devastating, impact on patients, according to new research presented at the ATS 2017 International Conference.
Drug discovery and development company SCYNEXIS, Inc. today announced that the Company has been awarded four grants totaling $977,917 under the U.S. Federal Government's Qualifying Therapeutic Discovery Project (QTDP). SCYNEXIS is developing a proprietary internal pipeline of cyclophilin inhibitors, a class of drugs that hold significant potential for the treatment of a broad range of diseases.
In the wake of multiple state bans on caffeinated alcoholic beverages (CABs) and an FDA warning to four companies to remove their products from the marketplace, an article published online today in the American Journal of Preventive Medicine delineates the scope of the public health problem and suggests areas of research that might help address it.
A national group of researchers, medical bodies and charities, led by The University of Manchester is looking for help in setting the top priorities for fighting womb cancer, with a survey launched today (23 March 2015).
Women's Health Weekly recently reported that America's pharmaceutical research and biotechnology companies are working on nearly 1,000 life-changing medicines for diseases affecting women, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). The medicines are awaiting approval by the U.S. Food and Drug Administration or are in human clinical trials.
› Verified 2 days ago
Dr. Michael E. Estess, M. D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1471 Shoreline Dr, Suite 119, Boise, ID 83702 Phone: 208-345-2630 Fax: 208-345-6504 | |
John Carr, PMHNP Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1000 N Curtis Rd Ste 202, Boise, ID 83706 Phone: 208-283-7314 | |
Eric A Simmons, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 335 Allumbaugh St, Boise, ID 83704 Phone: 208-376-1611 Fax: 208-658-1753 | |
Dr. Gary Falk, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise Vamc, Boise, ID 83702 Phone: 208-422-1108 | |
Karen Porth, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1072 N Liberty Street, Ste 303, Boise, ID 83704 Phone: 208-367-2800 Fax: 208-367-7111 | |
Ramon R Quijano, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 444 W Fort St., Fl 2, Boise, ID 83702 Phone: 208-422-1018 | |
Barbara J. Hagen, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 413 Allumbaugh St Ste 101, Boise, ID 83704 Phone: 208-323-1125 Fax: 208-323-9604 |